HUSCION is concentrating on the development of innovative novel entities such as the discovery of candidate and synthetic drugs from natural resources grown in South Korea. Through our intensive research on Panax Ginseng, Prasiola japonica, and 33 species of seaweed, we intend to contribute to the growth of the global pharmaceutical industry through the development of novel drugs to treat various diseases such as Alzheimer’s disease and atopic dermatitis, that are currently incurable by drugs approved by the Regulatory Authority.

For healthy longevity and improved quality of life of humankind, and not just living longer than a 100 years, HUSCION is conducting research such as discovery of novel entities, molecular level cell investigation, in vivo assay, and component analysis with the aim to present solutions for safer and more effective treatment, thereby enhancing health.

With achievements in applications such as health technology, technology-applied industrialization through investigation of novel drug candidates based on various sources, and patenting, HUSCION intends to become the most recognized corporation in the global health industry.